NCT02359461View on ClinicalTrials.gov

Evaluation of the Effect of Pulsatile Cuts Stendo3 on Vascular Function Patients With Diabetes Type 2

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

June 30, 2018

Conditions
Type 2 Diabetes
Interventions
DEVICE

Combination pulsatile Stendo3

Trial Locations (1)

63003

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
collaborator

STENDO, 17 rue du port 27400 LOUVIERS

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER

NCT02359461 - Evaluation of the Effect of Pulsatile Cuts Stendo3 on Vascular Function Patients With Diabetes Type 2 | Biotech Hunter | Biotech Hunter